GRFS News and Press, Grifols S.A. From 04/09/21

Grifols 2020 Annual Report on Form 20-F filed with the SEC on April 9, 2021 PR Newswire BARCELONA, Spain , April 9, 2021 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF), (MCE: GRF.P) and (NASDAQ: GRFS) announced that it has filed its 2020 Annual Report ...

Grifols installs first-ever DG Reader Net analyzer in North America - ThedaCare Medical Center-Wild Rose in Wisconsin is the first hospital in the U.S. and Canada to implement the DG Reader Net analyzer, helping automate pre-transfusion blood type matching and enhance patient sa...

Companhia Brasileira de Distribuicao (CBD) -76%.Soleno Therapeutics (SLNO) -26% after providing update on DCCR for the treatment of Prader-Willi syndromeSify Technologies (SIFY) -15%.Luokung Technology (LKCO) -15% after receipt of Nasdaq notification letter and a request for emergen...

The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in emergency room patients with mild to moderate symptoms of COVID-19.Following a second planned interim analysis of the trial data, an independent d...

Grifols, S.A. (GRFS) has acquired 25 U.S.-based plasma donation centers from BPL Plasma Inc., a subsidiary of Bio Products Laboratory Holdings Limited.Financed through Grifols’ own resources, the transaction valued at $370M will not necessitate any debt issuance, the company said.With ...

Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS' for fifth consecutive year -- Prestigious healthcare research firm reaffirms PharmacyKeeper Verification as the No. 1 product for Intravenous (IV) Workflow Management -- PharmacyKeeper Verification is a strategic part of ...

SAN CARLOS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases and a subsidiary of Grifols, today announced the publication of a peer-reviewed article i...

Good prospects for the global immunoglobulin business. Koru Medical's strategic plan is to reach $ 50M in sales by 2022, a gross margin of 70%, and organic and annual sales growth of + 20%. I understood that the Koru Medical investment thesis could be valid in the US as long as th...

The Dow Jones Sustainability Index recognizes Grifols as one of the world's most sustainable companies PR Newswire BARCELONA, Spain, Nov. 16, 2020 BARCELONA, Spain , Nov. 16, 2020 /PRNewswire/ -- Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a global health...

Soros's 13F portfolio value decreased from $4.48B to $4.08B this quarter. The number of positions decreased from 141 to 132. Soros added Palantir Technologies and Unity Software, while reducing T-Mobile US. Also, most of their recent additions in Financials were either reduced or elim...